Additional European Equity News - 15th September 2026

A mixed early-session European wrap of this kind rarely moves indices; the read is item by item.

Newsquawk StaffPublished 15 Sept 2026, 06:47 UTCOn the live feed at 06:27 UTC — 7 more headlines followed before this page went public

Newsquawk headlinesUTC

06:38

Iranian government aircraft that departed Tehran is reportedly preparing to land in Saudi Arabia, raising speculation that an Iranian delegation may be heading to Riyadh amid escalating Saudi-Houthi tensions, Kann News reporter says

06:33

Iran's IRGC says controlled explosions may be heard in southern Isfahan province until 13:00 local time today

06:27

Additional European Equity News - 15th September 2026

06:25

Goldman Sachs cuts its China 2026 GDP growth forecast to 4.5% from 4.6% (vs China's official target of 4.5%-5.0%)

06:21

[CALENDAR ADDITION] US Treasury Secretary Bessent to testify on the State of the International Financial System in front of the House Financial Services Committee at 10:00EDT/15:00BST

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free

Free. No signup, no card.

Big Yellow Group (BYG LN) - Co. announces that it has contracted to sell its industrial estate in Staines, Surrey for GBP 36.5mln and has received the GBP 2mln retention held back from the previously announced sale of its Harrow industrial estate. (Big Yellow Group)

GSK (GSK LN) - Co. announces that it has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) from Chimagen Biosciences, with plans to develop and commercialise the asset for multiple myeloma, with the programme expected to enter phase I trials in 2027. (GSK)

Novo Nordisk (NOVOB DC) - Ascendis Pharma (ASND) plans to advance once-monthly TransCon Semaglutide for obesity and type 2 diabetes after regaining exclusive metabolic and cardiovascular rights from Novo Nordisk. The terminated collaboration will return all related licences to Ascendis with no continuing financial obligations between the companies. (Ascendis)

Prysmian (PRY IM) - Co. announces that the acquisition of Atkore (ATKR) has received US antitrust clearance. (Prysmian)

Tele2 (TEL2B SS) - Co. appoints Vahdat Zehtab as EVP Chief Commercial Officer. (Tele2)

Telefonica (TEF SM) - Co. enters into an agreement with DAZN for the distribution of La Liga package for 5 seasons, valued at EUR 330mln on average per season. (Newswires)

TotalEnergies (TTE FP) - Co. announces a 3-year joint programme with Mistral, with investment totalling over EUR 100mln, to develop a new generation of frontier AI models to support TotalEnergies' geosciences experts in the exploration, characterisation and development of oil and gas reservoirs. (TotalEnergies)

AstraZeneca (AZN LN) upgraded to Hold from Sell at Deutsche Bank

Context

The GSK trispecific TCE deal follows the established large-pharma pattern of early-stage oncology licensing, where the partner takes trial and commercialisation risk and the market reaction is typically muted until clinical data arrive, given how few phase I entrants reach approval. The Ascendis/Novo Nordisk unwind is the more consequential strand: rights returns of this kind have historically signalled a narrowing of the originator's pipeline focus, and it hands Ascendis a monthly dosed competitor in the incretin space, a segment where dosing frequency has been the principal axis of differentiation. The Prysmian antitrust clearance fits the usual sequence in cable consolidation, where regulatory milestones, not signing, drive the spread; US clearance on cross-border industrial deals has tended to be the binding constraint. The Telefonica sports rights agreement extends a pattern of telecom operators paying up for football content as a churn anchor, with the margin question hinging on distribution economics rather than headline value. The TotalEnergies and Mistral programme is consistent with the majors' practice of buying AI capability via partnerships rather than builds, a low-capital item with no established earnings transmission channel. The Deutsche Bank upgrade on AstraZeneca is a single-house view and follows form as a flow item only.

Equities · last 90 days

Recent headlines that moved markets

EQUITIES/14 Sept · 16:48 UTC

US seeks "Step-by-Step" agreement with Iran, reports ILNA citing Pakistani sources.

- ES 500 (U6), after we published+0.2%

An update which lifted sentiment across US equity futures.

EQUITIES/14 Sept · 15:33 UTC

US President Trump says Iran wants to make a deal, quickly and badly. I will determine whether or not the U.S.A. will choose to engage - The concept of which we are open to.

- E-mini S&P 500 futures (U6), after we published+0.4%

EQUITIES/8 Sept · 05:24 UTC

Saudi Energy Minister says a number of energy facilities and utilities were hit; are temporarily halting some operations.

Equity indices, after we published−0.3%

EQUITIES/3 Sept · 04:54 UTC

North Korea stripped references to "peaceful unification" with South Korea from the charter of its ruling Workers' Party of Korea, according to Yonhap.

Equity indices, after we published−3.3%

EQUITIES/1 Sept · 16:17 UTC

Initial reports of an American attack on Iran, reports i24's Stein.

ES, after we published−0.2%

EQUITIES/26 Aug · 12:56 UTC

States and Meta (META) and agree to settle claims that platforms harmed children, according to a court filing; Meta agrees to pay a maximum of USD 16.68bln to states as part of deal

Market, after we published+2.6%

Newsquawk Daily

Get both market opens in your inbox.

This note and the other one — the EU open and the US open, every business day, written by the desk. No account needed.

Related headlines

The whole workspace, free to try.

© 2026 Newsquawk. All rights reserved.